OtherReview
Points to Consider when using KPIs/Metrics
Bernhard Hinsch, Sven Alexander Moritz, Ana Isabel Esteban Nunez, Timothy E. Orzula, Daniel Taylor and Alexander Nezlin
PDA Journal of Pharmaceutical Science and Technology June 2021, pdajpst.2020.012401; DOI: https://doi.org/10.5731/pdajpst.2020.012401
Bernhard Hinsch
1 Hinsch Consulting;
Sven Alexander Moritz
2 Sanofi-Aventis Deutschland GmbH;
Ana Isabel Esteban Nunez
3 Pfizer Compliance Division;
Timothy E. Orzula
4 Alkermes, External Commercial Quality Assurance;
Daniel Taylor
5 AstraZeneca, Corporate Quality;
Alexander Nezlin
6 UroGen Pharma
In This Issue
PDA Journal of Pharmaceutical Science and Technology
Vol. 78, Issue 2
March/April 2024
Points to Consider when using KPIs/Metrics
Bernhard Hinsch, Sven Alexander Moritz, Ana Isabel Esteban Nunez, Timothy E. Orzula, Daniel Taylor, Alexander Nezlin
PDA Journal of Pharmaceutical Science and Technology Jun 2021, pdajpst.2020.012401; DOI: 10.5731/pdajpst.2020.012401
Jump to section
Related Articles
- No related articles found.
Cited By...
- No citing articles found.
More in this TOC Section
Similar Articles